- Investing Ideas
- Canadian Pharmaceuticals & Biotech Healthy potentially undervalued
Canadian Pharmaceuticals & Biotech Healthy potentially undervalued
Results
10
Companies which are potentially undervalued and in an acceptable financial position.
10 companies
High Tide
Market Cap: CA$296.9m
Engages in the cannabis retail business in Canada, the United States, and internationally.
HITI
CA$3.40
7D
-5.6%
1Y
0.3%
Green Thumb Industries
Market Cap: CA$2.1b
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
GTII
CA$8.55
7D
-5.0%
1Y
-13.2%
Verano Holdings
Market Cap: CA$523.1m
Operates as a vertically integrated multi-state cannabis operator in the United States.
VRNO
CA$1.44
7D
-5.3%
1Y
44.0%
Curaleaf Holdings
Market Cap: CA$2.5b
Engages in the retail and wholesale of cannabis products in the United States and internationally.
CURA
CA$3.04
7D
-8.7%
1Y
102.7%
Medexus Pharmaceuticals
Market Cap: CA$103.0m
Operates as a pharmaceutical company in Canada and the United States.
MDP
CA$3.16
7D
9.7%
1Y
19.7%
TerrAscend
Market Cap: CA$337.4m
TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.
TSND
CA$0.85
7D
-7.6%
1Y
44.1%
Decibel Cannabis
Market Cap: CA$57.7m
An integrated cannabis company, engages in the cannabis cultivation in Canada.
DB
CA$0.10
7D
5.0%
1Y
40.0%
Aurora Cannabis
Market Cap: CA$283.0m
Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.
ACB
CA$4.80
7D
-9.6%
1Y
-31.0%
Trulieve Cannabis
Market Cap: CA$1.7b
Operates as a cannabis retailer in the United States.
TRUL
CA$8.31
7D
-7.2%
1Y
40.6%
Organigram Global
Market Cap: CA$258.1m
Engages in the production and sale of cannabis and cannabis-derived products in Canada.
OGI
CA$1.99
7D
0%
1Y
29.2%